Target intelligence / Profile preview

Endogenous antioxidant defense mechanisms

Molecular classification
Enzyme (e.g., superoxide dismutase, catalase, glutathione peroxidase), Redox protein (e.g., thioredoxin, peroxiredoxin, glutaredoxin), Small molecule (e.g., glutathione, melatonin)
01

Overview

Endogenous antioxidant defense mechanisms comprise the body's primary means of protecting itself from oxidative stress via a network of enzymes (such as superoxide dismutase, catalase, and glutathione peroxidase) and non-enzymatic molecules (such as glutathione and melatonin). These systems neutralize reactive oxygen and nitrogen species, repair or mitigate oxidative damage, and maintain redox balance, serving crucial roles in preventing cardiovascular, neurodegenerative, cancerous, and other oxidative stress-related diseases. Because this refers to a biological process rather than a distinct molecule or receptor, it is not considered a canonical therapeutic target and encompasses a variety of molecular entities acting together.

Other names
Endogenous antioxidant systemAntioxidant defense systemCellular antioxidant networkEndogenous antioxidant pathway
02

Mechanism of action

Scavenging of reactive oxygen species Catalysis of redox reactions (conversion of ROS to less harmful species) Regeneration of other antioxidants (e.g., GSH regenerates oxidized vitamin C and E) Upregulation of antioxidant enzyme expression (e.g., via Nrf2 signaling)

03

Biological functions

Neutralization of free radicals (ROS and RNS)Reduction of oxidative stressMaintenance of cellular homeostasisRegulation of redox signaling pathwaysPrevention of oxidative damage to DNA, proteins, and lipids
04

Disease associations

Cardiovascular disease (protection against ROS-induced damage)Neurodegenerative disease (linked to abnormal antioxidant levels)Cancer (oxidative stress-related mutations)Inflammation (ROS-mediated tissue injury)Aging (oxidative damage accumulation)Other (general tissue injury from oxidative stress)
05

Safety considerations

Over-supplementation of antioxidants may disrupt normal redox signalingPotential for reduced efficacy if antioxidant defenses are overwhelmed in advanced diseaseInterference with beneficial ROS signaling at high dosesPossible pro-oxidant effects at high concentrations
06

Interacting drugs

Antioxidant drugs and supplements (e.g., N-acetylcysteine, melatonin)

2 more in the full profile.

07

Biomarkers

Glutathione/GSSG ratioLevels or activities of SOD, catalase, GPxNrf2 pathway markersOxidative damage products (e.g., malondialdehyde, protein carbonyls)

Beyond the preview

Go deeper on Endogenous antioxidant defense mechanisms.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous antioxidant defense mechanisms.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call